Literature DB >> 16043676

Breast biopsy utilization: a population-based study.

Karthik Ghosh1, L Joseph Melton, Vera J Suman, Clive S Grant, Sylvester Sterioff, Kathy R Brandt, Charles Branch, Thomas A Sellers, Lynn C Hartmann.   

Abstract

BACKGROUND: Breast biopsy, to determine the nature of a clinical or radiographic breast abnormality, was presumed to have increased in frequency with the widespread use of screening mammography. However, scant data exist regarding the utilization of breast biopsies in the community population.
METHODS: Through the resources of the Rochester Epidemiology Project, the medical records of women 18 years and older who had a breast biopsy from January 1, 1988, through December 31, 1999, were reviewed for the type of biopsy, presentation at biopsy, and tissue pathological findings. The overall and age-specific utilization rates of breast biopsies were assessed, as were changes in the breast biopsy technique after the introduction of image-guided core-needle biopsy in 1992.
RESULTS: The overall annual utilization rate of breast biopsies was 62.6 per 10 000 women per year and remained stable throughout the study. Excisional breast biopsies showed a decreasing trend and core-needle biopsies increased during the study duration. The age-adjusted incidence of benign results of breast biopsies for the study duration was 38.9 per 10 000 women. The benign-malignant ratio remained constant despite changes in the biopsy procedure.
CONCLUSIONS: This population-based study provides much-needed data regarding the frequency of breast biopsies and benign results of breast biopsies in a community population. The utilization rate of breast biopsies remained fairly constant throughout the study period despite the introduction of the image-guided, core-needle biopsy procedure in 1992. A multidisciplinary breast practice, along with established guidelines for breast biopsy, can ensure appropriate use of new technology and thereby improve patient care.

Entities:  

Mesh:

Year:  2005        PMID: 16043676     DOI: 10.1001/archinte.165.14.1593

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008.

Authors:  Jasvinder A Singh; Michael B Vessely; W Scott Harmsen; Cathy D Schleck; L Joseph Melton; Robert L Kurland; Daniel J Berry
Journal:  Mayo Clin Proc       Date:  2010-09-07       Impact factor: 7.616

2.  ERβ expression and breast cancer risk prediction for women with atypias.

Authors:  Tina J Hieken; Jodi M Carter; John R Hawse; Tanya L Hoskin; Melanie Bois; Marlene Frost; Lynn C Hartmann; Derek C Radisky; Daniel W Visscher; Amy C Degnim
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

3.  The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions.

Authors:  Mehmet U S Ayvaci; Oguzhan Alagoz; Elizabeth S Burnside
Journal:  Manuf Serv Oper Manag       Date:  2012-04       Impact factor: 7.600

4.  Decreasing utilization of hysterectomy: a population-based study in Olmsted County, Minnesota, 1965-2002.

Authors:  Ebenezer O Babalola; Adil E Bharucha; Cathy D Schleck; John B Gebhart; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Obstet Gynecol       Date:  2007-03       Impact factor: 8.661

5.  Utilization of surgical procedures for pelvic organ prolapse: a population-based study in Olmsted County, Minnesota, 1965-2002.

Authors:  Ebenezer O Babalola; Adil E Bharucha; L Joseph Melton; Cathy D Schleck; Alan R Zinsmeister; Christopher J Klingele; John B Gebhart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-05-27

6.  p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.

Authors:  Derek C Radisky; Marta Santisteban; Hal K Berman; Mona L Gauthier; Marlene H Frost; Carol A Reynolds; Robert A Vierkant; V Shane Pankratz; Daniel W Visscher; Thea D Tlsty; Lynn C Hartmann
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-15

7.  Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.

Authors:  Jingfang Cheng; Shijing Qiu; Usha Raju; Sandra R Wolman; Maria J Worsham
Journal:  Breast Cancer Res Treat       Date:  2007-10-05       Impact factor: 4.872

8.  Using Machine Learning to Identify Benign Cases with Non-Definitive Biopsy.

Authors:  Finn Kuusisto; Inês Dutra; Houssam Nassif; Yirong Wu; Molly E Klein; Heather B Neuman; Jude Shavlik; Elizabeth S Burnside
Journal:  Healthcom       Date:  2013-10-09

9.  Logical Differential Prediction Bayes Net, improving breast cancer diagnosis for older women.

Authors:  Houssam Nassif; Yirong Wu; David Page; Elizabeth Burnside
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

10.  Pursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis.

Authors:  Yirong Wu; Oguzhan Alagoz; David J Vanness; Amy Trentham-Dietz; Elizabeth S Burnside
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.